Can You Take Wegovy When Trying to Get Pregnant?

Is it safe to take Wegovy if you are trying to conceive?

The short answer is no. Neither semaglutide nor any other GLP-1 receptor agonist currently licensed in the UK carries a recommendation that it is safe to use when actively trying to get pregnant. The MHRA advises that women of childbearing potential use effective contraception while on these medicines, and that a wash-out period should be completed before attempting to conceive. The reason is precautionary: data from human pregnancies is limited, and animal studies with semaglutide showed adverse developmental effects at doses relevant to human use. That is not a definitive answer about what would happen in a human pregnancy, but it is enough for regulators to say: stop treatment first.

The NHS England guidance on weight-management injections covers this directly and consistently with the SmPC for Wegovy. If you are reading this because your plans have changed recently, the practical thing to do is read through the Wegovy treatment page so you have the full clinical picture, then speak to whoever prescribed it. That conversation needs to happen before you stop, not after.

It is also worth checking whether you can get pregnant on Wegovy, including what the guidance says about fertility and contraception during treatment. For women on Wegovy, there is no confirmed evidence that the pill's absorption is reduced in the same way it is for tirzepatide, but gut-motility changes during GLP-1 treatment are real and worth raising with your GP if you have any doubt.

How long should you stop Wegovy before trying to get pregnant?

The MHRA's position, reflected in the Wegovy Patient Information Leaflet, is that treatment should be stopped before trying to conceive, with a wash-out period observed. The specific duration referenced in UK guidance is two months. This reflects how long semaglutide remains detectable in the body after the last dose, given its roughly one-week half-life in circulation. Two months gives several half-lives of clearance.

This is not a target to hit and then immediately start trying. It is a minimum, and your GP or prescriber may advise differently based on your individual circumstances, your cycle, and what weight-management support you will use in the interim. The relationship between Wegovy and pregnancy is a topic that deserves a proper conversation rather than a search result acting as a substitute for clinical advice.

What is less certain is how quickly weight regain might occur after stopping, and how to manage that in the lead-up to and during a pregnancy. Both questions are worth raising proactively. Obesity in pregnancy carries its own risks, which is part of why this is a nuanced decision rather than a simple one.

What if you are already pregnant and still taking Wegovy?

Contact your GP or prescribing clinician promptly. This is not a situation that warrants alarm, but it does need a conversation soon rather than at your next scheduled review. Wegovy is not recommended during pregnancy, and the clinical guidance is to stop it. Your healthcare team will want to talk through your weight management going forward and arrange appropriate monitoring.

The question of taking Wegovy during pregnancy is addressed in detail in its own page, including what the evidence does and does not show. For information specifically about the risks and considerations of semaglutide in pregnancy, that resource covers the clinical position in full.

If you are unsure whether your prescriber is the right first call or your GP should be involved, the answer is usually both, and the sooner the better. You can also contact the nume support team if you are a current patient and need guidance on next steps.

What happens to your weight management while you are trying to conceive?

This is the question that often goes unasked. Stopping Wegovy removes the appetite-suppressing effect, and for many people that means appetite returns fairly quickly, sometimes within days of the last dose. Weight regain in the months after stopping is documented in the trial data, it is not a personal failure, it reflects the medicine's mechanism.

That does not mean there is nothing to do. A conversation with your GP about diet, activity, and any non-pharmacological support available is a reasonable next step. Some people start that planning before they stop treatment, so there is a structure in place from day one. The weight-loss treatment overview gives context on the options available, and our clinical team is happy to discuss where you stand before or after you make a decision about stopping.

If you are wondering whether you can take semaglutide when pregnant, the current guidance reviewed by the MHRA and NHS England is clear that you should not. But that guidance also does not leave you without options, and planning the transition off treatment is very much part of responsible clinical care. Speak to whoever manages your treatment, and if you do not have a prescriber in place, a free consultation with our prescribers can help you understand where you stand.